| 01/03/2019 |
EU funding: Epigenome maintenance in response to DNA damage |
| 01/03/2019 |
EU funding (€1,000,000): RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients |
| 17/10/2019 |
EU funding (€1,237,400): Visualizing Death Inducing Protein Complexes |
| 01/01/2019 |
EU funding (€1,497,441): Nociception and sensory nerves as regulators of type 2 immunity and skin inflammation |
| 14/02/2019 |
EU funding (€1,500,000): Regulation of synaptic development and plasticity by molecular pathways linked to human evolution |
| 21/06/2019 |
EU funding (€1,850,000): Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease |
| 12/09/2019 |
EU funding (€1,999,391): Metabolic integration by nutrient SENSing |
| 01/01/2019 |
EU funding (€11M): ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND) |
| 20/06/2019 |
EU funding (€12.3M): NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW |
| 18/04/2019 |
EU funding (€122,678): Self-Healing Hydrogels for Material-Assisted Cell therapy in Osteoarthritis |
| 01/01/2019 |
EU funding (€14.2M): Genome, Environment, Microbiome & Metabolome in Autism: an integrated multi-omic systems biology approach to identify biomarkers for personalized treatment and primary prevention of Autism Spectr |
| 01/05/2019 |
EU funding (€146,227): Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging |
| 01/04/2019 |
EU funding (€146,227): Induction of B cell immunity in the lung mucosa |
| 01/04/2019 |
EU funding (€15.3M): Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation |
| 13/08/2019 |
EU funding (€150,000): A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) |
| 30/04/2019 |
EU funding (€150,000): Translating fundamental insights in podocyte metabolism and cell cycle regulation: development of a new treatment for Stopping crescentic Immune Glomerulonephritis |
| 01/01/2019 |
EU funding (€15M): Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. |
| 01/01/2019 |
EU funding (€15M): Induced pluripotent stem cell-based therapy for spinal regeneration |
| 01/03/2019 |
EU funding (€17.8M): Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts |
| 03/05/2019 |
EU funding (€184,708): Language and Brain Rhythms |
| 27/04/2019 |
EU funding (€184,708): Using PML nuclear body biology to identify potential AML treatment targets |
| 03/05/2019 |
EU funding (€196,708): Fecal miRNAs, new mediators of host-microbiota interaction in Inflammatory Bowel Disease |
| 01/05/2019 |
EU funding (€196,708): Mechanosensing and Mitral Valve Prolapse: from the Molecular Mechanisms to the Progression of the Disease |
| 03/06/2019 |
EU funding (€196,708): P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis |
| 04/05/2019 |
EU funding (€196,708): REstoring myocardial repair capacity via the modulation of MAcrophage-mediated cytoKINe secretion. |
| 01/01/2019 |
EU funding (€2,106,800): African Research and Innovative Initiative for Sickle cell Education: Improving Research Capacity for Service Improvement |
| 28/08/2019 |
EU funding (€2,496,210): Unravelling the secretion machinery for virulence factors in apicomplexan parasites |
| 11/06/2019 |
EU funding (€2,499,969): Targeting endothelial barriers to combat disease |
| 17/10/2019 |
EU funding (€2,499,995): Deconstructing the role of SUMO on chromatin in cell identity and tissue repair |
| 13/08/2019 |
EU funding (€2,672,562): The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance |
| 04/09/2019 |
EU funding (€2,999,999): Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. |
| 14/01/2019 |
EU funding (€26.1M): Providing an open collaborative space for digital biology in Europe |
| 01/01/2019 |
EU funding (€3,097,323): Integrating Environment and Health Research: a Vision for the EU |
| 01/01/2019 |
EU funding (€3,316,013): Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics |
| 01/07/2019 |
EU funding (€3,429,217): Antibiotic Distribution and Recovery in Tissue |
| 30/09/2019 |
EU funding (€3,604,780): Non-invasive dynamic neural control by laser-based technology |
| 01/05/2019 |
EU funding (€3,664,174): ENdoThelial macRophage Alliance In Neuroinflammation |
| 01/06/2019 |
EU funding (€3,969,936): AGE-RELATED CHANGES IN HEMATOPOIESIS |
| 13/08/2019 |
EU funding (€3,992,397): Molecular basis of human enhanceropathies |
| 28/08/2019 |
EU funding (€3,993,480): Erythrocytes properties and viability in dependence of flow and extra-cellular environment |
| 01/01/2019 |
EU funding (€3,996,150): FAIRplus |
| 28/08/2019 |
EU funding (€4,017,848): Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery |
| 17/09/2019 |
EU funding (€4,023,617): A nanovaccine Approach for the treatment of Pancreatic Cancer |
| 23/09/2019 |
EU funding (€4,076,578): Secretion, Autophagy and their role in Neurodegeneration |
| 06/09/2019 |
EU funding (€4,088,951): COmplement Regulation and Variations in Opportunistic infectionS |
| 29/08/2019 |
EU funding (€4,099,782): ONCOgenic Receptor Network of Excellence and Training 2.0 |
| 27/11/2019 |
EU funding (€4,822,197): Human Gonad Developmental Cell Atlas |
| 08/11/2019 |
EU funding (€4,948,385): Integrated silicon photonics for Cardiovascular Disease monitoring |
| 28/08/2019 |
EU funding (€40.3M): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions |
| 01/01/2019 |
EU funding (€5,499,882): Vaccines and Infectious Diseases in the Ageing PopuLation |
| 01/01/2019 |
EU funding (€5,998,456): Common Infrastructure for National Cohorts in Europe, Canada, and Africa |
| 20/05/2019 |
EU funding (€5,999,886): The regulatory GENomE of SWine and CHicken: functional annotation during development |
| 01/01/2019 |
EU funding (€55.1M): European Joint Programme on Rare Diseases |
| 03/05/2019 |
EU funding (€57,646): Merkel cell polyomavirus Oncogenic Network |
| 26/11/2019 |
EU funding (€6,000,000): Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy |
| 27/11/2019 |
EU funding (€6,000,000): Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity |
| 01/01/2019 |
EU funding (€6,104,476): Female Reproductive toxicity of EDCs: a human evidence-based screening and Identification Approach |
| 27/11/2019 |
EU funding (€6,256,759): 3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients |
| 01/03/2019 |
EU funding (€6,700,000): CARdiomyopathy in type 2 DIAbetes mellitus |
| 01/01/2019 |
EU funding (€6,761,834): Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds |
| 01/07/2019 |
EU funding (€6,880,965): Coordination and Harmonisation of National Inititiatives, Infrastructures and Data services in Central and Western Europe |
| 21/05/2019 |
EU funding (€6,999,989): Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs |
| 02/07/2019 |
EU funding (€799,916): STRENGTHENING THE SFAX UNIVERSITY EXPERTISE FOR DIAGNOSIS AND MANAGEMENT OF EPILEPTIC ENCEPHALOPATHIES |
| 27/11/2019 |
EU funding (€8,064,946): Gene Therapy to restore lymphatic flow lymphedema |
| 01/01/2019 |
EU funding (€8,200,000): NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients |
| 01/01/2019 |
EU funding (€8,480,544): A testing bed for the development of high-risk medical devices |
| 01/03/2019 |
EU funding (€9,866,250): Well-Aging and the Tanycytic Control of Health |
